Lupin Limited - India's Leading Pharma Company

            
 
Strategic Management|Management Strategy |Business Strategy Case Study|Business Strategy|Case Study|Case Studies

ICMR HOME | Case Studies Collection

To download Lupin Limited - India's Leading Pharma Company case study (Case Code: BSTR191) click on the button below, and select the case from the list of available cases:

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies

OR


Buy With PayPal

Amount to be paid:



Prefer to pay in another currency ?
Select Currency for Payment



Exchange Rates: Click Here
Delivery Details: Click Here

Business Strategy Case Studies
Case Studies Collection
Business Strategy Short Case Studies
View Detailed Pricing Info
How To Order This Case
Business Case Studies
Case Studies by Area
Case Studies by Industry
Case Studies by Company

Custom Search



Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.



Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

Leave Your Feedback

ICMR India ICMR India ICMR India ICMR India RSS Feed

Case Details:

Price:

Case Code : BSTR191 Electronic Format: Rs. 300;
Courier (within India):Rs. 25 Extra
Business Strategy | Case Study in Management, Operations, Strategies, Business Strategy, Case Studies

Themes

Growth Strategy
Case Length : 14 Pages
Period : 1998-2005
Organization : Lupin Laboratories
Pub Date : 2006
Teaching Note : Not Available
Countries : India
Industry : Pharma and Biotech

Abstract:

The case presents the strategies adopted by Lupin Limited to emerge as one of the leading pharmaceutical companies in India. For the fiscal 2004-05, Lupin reported revenues of Rs. 12.12 billion, placing it among the top six companies in the Indian pharma industry. The company aims at achieving the revenues of US$ 1 billion by 2009. To achieve this target, Lupin has made heavy investments in R&D, manufacturing processes and is focusing on exports. Notwithstanding Lupin's success till date and its plans for future growth, the company faces significant threat in the form of product patents, high debts and rising competition from both local and foreign pharma companies. The case highlights the challenges facing Lupin and its plans to overcome these challenges.

Business Strategy | Case Study in Management, Operations, Strategies, Business Strategy, Case Studies

Issues:

  Recent trends in the Indian Pharmaceutical Industry
Lupin's journey from a drug manufacturer to a national level pharma company
Growth Strategies of Lupin Limited
Importance of patents (product and process) in the pharma industry
Product patent regime in India

Contents:

  Page No.
Introduction 2
The Indian Pharmaceutical Industry 3
About Lupin 4
The Success Saga 6
Going Global 8
The Road Ahead 8
Exhibits 10

Keywords:

Lupin Limited, Indian Pharmaceutical Industry, Product patent, Process patents, Active pharmaceutical ingredients, Drug price control, Generics, Anti-tuberculosis Drugs, Pediatrics segment, Over-the-counter drugs

Lupin Limited - India's Leading Pharma Company - Next Page>>

 

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.